Cargando...
Relevance of genetic alterations in squamous and small cell lung cancer
The precision medicine revolution has led to the development and US FDA approval of multiple targeted therapies in non-squamous non-small cell lung cancers, including tyrosine kinase inhibitors targeting EGFR, ALK, and ROS1. However, the development of targeted therapies for squamous cell lung cance...
Guardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635252/ https://ncbi.nlm.nih.gov/pubmed/29057233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.06.72 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|